Orphazyme A/S (ORPHA.CO)
| Previous close | 2.2280 |
| Open | 2.1020 |
| Bid | 2.1000 x 0 |
| Ask | 2.1380 x 0 |
| Day's range | 2.0040 - 2.1960 |
| 52-week range | 1.1000 - 54.6500 |
| Volume | |
| Avg. volume | 208,558 |
| Market cap | 73.4M |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -25.5510 |
| Earnings date | 15 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 108.00 |
- Globe Newswire
Updated notice to holders of ADSs regarding termination of Deposit Agreement
Orphazyme A/SCompany announcement No. 32/2022www.orphazyme.comCompany Registration No. 32266355 NOTICE TO HOLDERS OF AMERICAN DEPOSITARY SHARES (“ADSs”) EVIDENCED BYAMERICAN DEPOSITARY RECEIPTS (“ADRs”) REPRESENTING DEPOSITED COMMON SHARES OF:ORPHAZYME A/S ONE ADS REPRESENTS ONE COMMON SHARECUSIP: 687305102 AND UNDERLYING ISIN: DK0060910917 Copenhagen, Denmark, June 20, 2022 – Orphazyme A/S (ORPHA.CO) (“Orphazyme” or the “Company”), hereby provides notice to holders of American Depositary Shares
- Globe Newswire
Correction: Orphazyme Announces Publication of 2021 Financial Results and Annual Report
Orphazyme A/SCompany announcementNo. 30/2022 Annual reportwww.orphazyme.com Company Registration No. 32266355 [Correction: Hereby including the ESEF versions] Copenhagen, Denmark, June 7, 2022 – Orphazyme A/S (ORPHA.CO) (“Orphazyme” or the “Company”), today reports its financial results for the period from January 1, 2021, to December 31, 2021, and publishes its Annual Report. In 2021, and until recently, the primary focus of Orphazyme was on seeking marketing authorization in the United States
- Globe Newswire
Notice to convene Annual General Meeting
Orphazyme A/SCompany announcementNo. 31/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, June 7, 2022 – Orphazyme A/S (ORPHA.CO) (the “Company”), today announces the notice to convene the Company’s Annual General Meeting to be held on: Wednesday, June 29, 2022, at 2:00 PM (CEST) at the offices of Gorrissen Federspiel, Axeltorv 2, DK-1609 Copenhagen V. The notice to convene the Annual General Meeting, including Appendix 1: Candidates for the Board of Directors is attach
